Non-Current Assets
Available-for-Sale Securities (Non-Current)
Merck & Co. Available-for-Sale Securities (Non-Current) decreased by 14.4% to $956.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 106.5%, from $463.00M to $956.00M. Over 5 years (FY 2020 to FY 2025), Available-for-Sale Securities (Non-Current) shows an upward trend with a 4.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ3 2015
Last reportedQ4 2025
Metric ID:
afs_securities_noncurrentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $411.00M | $435.00M | $370.00M | $316.00M | $238.00M | $984.00M | $1.02B | $1.29B | $1.21B | $1.31B | $252.00M | $280.00M | $357.00M | $575.00M | $463.00M | $616.00M | $774.00M | $1.12B | $956.00M |
| QoQ Change | — | +5.8% | -14.9% | -14.6% | -24.7% | +313.4% | +3.2% | +27.1% | -5.9% | +7.6% | -80.7% | +11.1% | +27.5% | +61.1% | -19.5% | +33.0% | +25.6% | +44.3% | -14.4% |
| YoY Change | — | — | — | — | -42.1% | +126.2% | +174.3% | +308.2% | +410.1% | +32.7% | -75.2% | -78.3% | -70.6% | -56.0% | +83.7% | +120.0% | +116.8% | +94.3% | +106.5% |
Range$238.00M – $1.31B
CAGR+20.6%
Avg YoY Growth+83.4%
Median YoY Growth+94.3%
Available-for-Sale Securities (Non-Current) at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s available-for-sale securities (non-current)?
- Merck & Co. (MRK) reported available-for-sale securities (non-current) of $956.00M in Q4 2025.
- How has Merck & Co.'s available-for-sale securities (non-current) changed year-over-year?
- Merck & Co.'s available-for-sale securities (non-current) increased by 106.5% year-over-year, from $463.00M to $956.00M.
- What is the long-term trend for Merck & Co.'s available-for-sale securities (non-current)?
- Over 5 years (2020 to 2025), Merck & Co.'s available-for-sale securities (non-current) has grown at a 4.0% compound annual growth rate (CAGR), from $785.00M to $956.00M.